Latest Articles
Endometriosis Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com
Endometriosis Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Domain | DelveInsight Barchart.com
Published: Feb. 12, 2026, 9:42 p.m.
The best President's Day deals already live: Shop TVs, mattresses, Apple, streaming, and more - Mashable
The best President's Day deals already live: Shop TVs, mattresses, Apple, streaming, and more Mashable
Published: Feb. 12, 2026, 5:43 p.m.
Applied Partnership Awards – Women’s Health 2026 (Ireland) - fundsforNGOs
Applied Partnership Awards – Women’s Health 2026 (Ireland) fundsforNGOs
Published: Feb. 12, 2026, 4:47 a.m.
Amazon's Presidents' Day sale is live — score huge deals on Apple, Lego, Roborock, and more - Mashable
Amazon's Presidents' Day sale is live — score huge deals on Apple, Lego, Roborock, and more Mashable
Published: Feb. 11, 2026, 9:30 p.m.
11-inch Apple iPad Pro (M5) deal: $899.99 at Amazon - Mashable
11-inch Apple iPad Pro (M5) deal: $899.99 at Amazon Mashable
Published: Feb. 11, 2026, 8:31 p.m.
Can this new app reduce endometriosis diagnosis waiting times? - Stylist
Can this new app reduce endometriosis diagnosis waiting times? Stylist
Published: Feb. 10, 2026, 3:45 p.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IBTimes India
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IBTimes India
Published: Feb. 10, 2026, 11:57 a.m.
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment - scanx.trade
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment scanx.trade
Published: Feb. 10, 2026, 10:22 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IANS LIVE
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IANS LIVE
Published: Feb. 10, 2026, 10:07 a.m.
AstraZeneca Shares Surge 3% on CDSCO Approval for Cancer Drug - Equitypandit
AstraZeneca Shares Surge 3% on CDSCO Approval for Cancer Drug Equitypandit
Published: Feb. 10, 2026, 9:36 a.m.
Link copied to clipboard!